Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)
504.97 x 1 602.00 x 1
Pre-market by (Cboe BZX)
511.74 +8.54 (+1.70%) 03/24/25 [NASDAQ]
504.97 x 1 602.00 x 1
Pre-market 509.20 -2.54 (-0.50%) 16:00 ET
Quote Overview for Mon, Mar 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
501.00
Day High
513.97
Open 505.00
Previous Close 503.20 503.20
Volume 1,237,600 1,237,600
Avg Vol 1,374,555 1,374,555
Stochastic %K 72.05% 72.05%
Weighted Alpha +23.41 +23.41
5-Day Change -2.02 (-0.39%) -2.02 (-0.39%)
52-Week Range 377.85 - 519.88 377.85 - 519.88
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 131,409,720
  • Shares Outstanding, K 256,790
  • Annual Sales, $ 11,020 M
  • Annual Income, $ -535,600 K
  • EBIT $ -233 M
  • EBITDA $ -26 M
  • 60-Month Beta 0.41
  • Price/Sales 11.73
  • Price/Cash Flow N/A
  • Price/Book 8.01

Options Overview Details

View History
  • Implied Volatility 24.09% ( -0.38%)
  • Historical Volatility 20.78%
  • IV Percentile 22%
  • IV Rank 18.23%
  • IV High 52.99% on 12/18/24
  • IV Low 17.64% on 05/16/24
  • Put/Call Vol Ratio 0.74
  • Today's Volume 1,335
  • Volume Avg (30-Day) 1,798
  • Put/Call OI Ratio 0.74
  • Today's Open Interest 32,174
  • Open Int (30-Day) 35,816

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 31 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 3.68
  • Number of Estimates 8
  • High Estimate 3.99
  • Low Estimate 3.27
  • Prior Year 4.29
  • Growth Rate Est. (year over year) -14.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
473.51 +8.07%
on 02/27/25
Period Open: 481.65
519.68 -1.53%
on 03/14/25
+30.09 (+6.25%)
since 02/24/25
3-Month
397.24 +28.82%
on 01/13/25
Period Open: 408.18
519.68 -1.53%
on 03/14/25
+103.56 (+25.37%)
since 12/24/24
52-Week
377.85 +35.43%
on 12/19/24
Period Open: 415.66
519.88 -1.57%
on 11/08/24
+96.08 (+23.12%)
since 03/22/24

Most Recent Stories

More News
Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

BMRN : 71.99 (+1.05%)
VRTX : 511.74 (+1.70%)
MRNA : 34.17 (+4.62%)
UTHR : 319.86 (+2.19%)
BIIB : 141.60 (+0.50%)
Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next

Equity markets started 2025 pretty well, but things haven't been so rosy in the past couple of months. The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this....

COMP : 9.61 (+2.34%)
VRTX : 511.74 (+1.70%)
DXCM : 75.32 (+2.06%)
A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

MYGN : 9.98 (-0.30%)
VRTX : 511.74 (+1.70%)
BMRN : 71.99 (+1.05%)
GILD : 106.74 (-0.32%)
MRNA : 34.17 (+4.62%)
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation

Are you reluctant to invest in stocks right now? That's understandable. Fear, uncertainty, and doubt have become the norm in early 2025 with rising stock market volatility .

NVO : 75.33 (-1.99%)
VRTX : 511.74 (+1.70%)
LLY : 864.90 (+3.26%)
3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now

Many investors view the healthcare sector as a safe haven when the stock market is turbulent. That's understandable. The demand for healthcare products and services typically holds up very well regardless...

KNSA : 23.41 (+0.21%)
VRTX : 511.74 (+1.70%)
AGN.AX : 0.800 (-2.44%)
ABBV : 209.17 (-0.40%)
3 Stocks With Ironclad Balance Sheets for Long-Term Stability

Check out these three stocks with balance sheets that have a case for being among the strongest in the entire stock market.

NVDA : 121.41 (+3.15%)
ANET : 87.51 (+5.27%)
VRTX : 511.74 (+1.70%)
REGN : 661.00 (+0.38%)
Company News for Mar 11, 2025

Shares of Vertex Pharmaceuticals Incorporated VRTX rose 2.4% on its cystic fibrosis drug Alyftrek getting approval in the United Kingdom.Shares of Tesla, Inc. TSLA plummeted 15.4% on the broad-based stock...

NVDA : 121.41 (+3.15%)
TSLA : 278.39 (+11.93%)
VRTX : 511.74 (+1.70%)
COIN : 203.04 (+6.94%)
Nasdaq Correction: The 2 Smartest Stocks to Buy and Hold Forever

When you're on an airplane, the pilot or a flight attendant will typically announce over the loudspeaker to "buckle your seatbelt" when the air is turbulent. That could be good advice for investors right...

COMP : 9.61 (+2.34%)
$NASX : 18,188.59 (+2.27%)
VRTX : 511.74 (+1.70%)
AMZN : 203.26 (+3.59%)
3 Reasons to Avoid VRTX and 1 Stock to Buy Instead

3 Reasons to Avoid VRTX and 1 Stock to Buy Instead

WING : 222.62 (+3.32%)
VRTX : 511.74 (+1.70%)
Where Will Vertex Pharmaceuticals Be in 10 Years?

The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX) . The biotech won approval for its first cystic fibrosis (CF) drug -- Kalydeco -- back in 2012 and has since gained...

VRTX : 511.74 (+1.70%)
MRNA : 34.17 (+4.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which...

See More

Key Turning Points

3rd Resistance Point 529.78
2nd Resistance Point 521.88
1st Resistance Point 516.81
Last Price 511.74
1st Support Level 503.83
2nd Support Level 495.93
3rd Support Level 490.86

See More

52-Week High 519.88
Last Price 511.74
Fibonacci 61.8% 465.62
Fibonacci 50% 448.86
Fibonacci 38.2% 432.11
52-Week Low 377.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals